Publications by authors named "Nathanael Gistand"
Clin Infect Dis
October 2024
Article Synopsis
- A study at the Ward 86 HIV clinic in San Francisco investigated the effectiveness of long-acting cabotegravir/rilpivirine (LA-CAB/RPV) in rapidly achieving and maintaining viral suppression in people with HIV who initially had high viral loads.
- Out of 59 participants who started LA-CAB/RPV with detectable viremia, 80% achieved sustained viral suppression after 48 weeks, while overall 92% had viral suppression when considering those who switched treatments.
- The findings suggest that LA-CAB/RPV can significantly aid individuals struggling with adherence to oral HIV medications, highlighting its potential as an effective long-term treatment option.
